American Portfolios Advisors’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $311K | Buy |
46,490
+3,540
| +8% | +$23.7K | 0.01% | 837 |
|
|
2022
Q2 | $273K | Hold |
42,950
| – | – | 0.01% | 912 |
|
|
2022
Q1 | $199K | Buy |
42,950
+235
| +0.6% | +$1.09K | 0.01% | 1160 |
|
|
2021
Q4 | $214K | Buy |
42,715
+13,155
| +45% | +$65.8K | 0.01% | 1129 |
|
|
2021
Q3 | $356K | Buy |
29,560
+1,125
| +4% | +$13.6K | 0.01% | 865 |
|
|
2021
Q2 | $601K | Buy |
28,435
+3,375
| +13% | +$71.4K | 0.02% | 632 |
|
|
2021
Q1 | $703K | Buy |
25,060
+2,875
| +13% | +$80.6K | 0.03% | 533 |
|
|
2020
Q4 | $577K | Buy |
22,185
+1,290
| +6% | +$33.5K | 0.03% | 515 |
|
|
2020
Q3 | $777K | Buy |
20,895
+6,140
| +42% | +$228K | 0.04% | 363 |
|
|
2020
Q2 | $757K | Buy |
14,755
+2,910
| +25% | +$149K | 0.05% | 337 |
|
|
2020
Q1 | $373K | Buy |
11,845
+7,425
| +168% | +$234K | 0.03% | 443 |
|
|
2019
Q4 | $264K | Buy |
4,420
+200
| +5% | +$11.9K | 0.02% | 641 |
|
|
2019
Q3 | $155K | Buy |
4,220
+200
| +5% | +$7.33K | 0.01% | 802 |
|
|
2019
Q2 | $187K | Sell |
4,020
-300
| -7% | -$14K | 0.02% | 735 |
|
|
2019
Q1 | $173K | Buy |
4,320
+475
| +12% | +$19.1K | 0.02% | 688 |
|
|
2018
Q4 | $177K | Hold |
3,845
| – | – | 0.02% | 551 |
|
|
2018
Q3 | $171K | Buy |
3,845
+700
| +22% | +$31.1K | 0.02% | 641 |
|
|
2018
Q2 | $123K | Sell |
3,145
-2,330
| -43% | -$91.3K | 0.02% | 728 |
|
|
2018
Q1 | $396K | Hold |
5,475
| – | – | 0.06% | 318 |
|
|
2017
Q4 | $360K | Buy |
+5,475
| New | +$360K | 0.06% | 333 |
|